Planta Med 2001; 67(1): 79-81
DOI: 10.1055/s-2001-10625
Letter

© Georg Thieme Verlag Stuttgart · New York

Cytotoxicity of Iridals, Triterpenoids from Iris, on Human Tumor Cell Lines A2780 and K562

Jean-Paul Bonfils1,*, Frédéric Pinguet2 , Stéphane Culine2 , Yves Sauvaire1
  • 1 Laboratoire de Recherche sur les Substances Naturelles Végétales, Université Montpellier II, France
  • 2 Laboratoire d'Oncopharmacologie et Service d'Oncologie, C.R.L.C. Val d'Aurelle, Montpellier, France
Weitere Informationen

Publikationsverlauf

February 17, 2000

May 21, 2000

Publikationsdatum:
31. Dezember 2001 (online)

Preview

Abstract

Six different triterpenoids (known iridals) extracted from Iris germanica L. were purified and bioassayed on two cultured human tumor cell lines: A2780 and K562 (and for each one a drug-sensitive and a drug-resistant cell line). All of the tested iridals had an IC50 in the 0.1 to 5.3 μg/ml range. Some of them were shown to be more effective than doxorubicine. Toxicity of iridals on multi-drug resistance (MDR) expressing cell lines seemed to indicate that the effects of these triterpenoids are less affected by MDR than those of doxorubicine or taxol.

References

Dr. Jean-Paul Bonfils

Laboratoire de Recherche sur les Substances Naturelles Végétales, UPR ES 1677

Université Montpellier II

Place Eugène Bataillon, cc 024

34095 Montpellier Cedex 5

France

eMail: bonfils@univ-montp2.fr

Fax: (00 33) 04 67 14 36 12